VERASTEM, INC. (VSTM)
Clinical trial NCT03287271 updates: 1. status: RECRUITING → TERMINATED 2. completion date: 2026-04-01 → 2025-03-12 3. primary completion date: 2025-04-01 → 2023-07-30 4. enrollment: 90 → 8 participants 5. enrollment type: ESTIMATED → ACTUAL 6. allocation: NA → NON_RANDOMIZED
📉 **NEGATIVE** • Medium confidence analysis (72%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (18%) **Content type:** Clinical